Livforsakringsbolaget Skandia Omsesidigt bought a new stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 3,700 shares of the company’s stock, valued at approximately $202,000.
Other hedge funds and other institutional investors have also made changes to their positions in the company. SG Capital Management LLC increased its stake in shares of Nu Skin Enterprises by 152.0% during the fourth quarter. SG Capital Management LLC now owns 202,946 shares of the company’s stock valued at $11,087,000 after purchasing an additional 122,420 shares in the last quarter. GWM Advisors LLC increased its stake in shares of Nu Skin Enterprises by 20.4% during the fourth quarter. GWM Advisors LLC now owns 7,432 shares of the company’s stock valued at $406,000 after purchasing an additional 1,258 shares in the last quarter. Wells Fargo & Company MN increased its stake in shares of Nu Skin Enterprises by 68.4% during the fourth quarter. Wells Fargo & Company MN now owns 217,190 shares of the company’s stock valued at $11,866,000 after purchasing an additional 88,236 shares in the last quarter. Teacher Retirement System of Texas bought a new position in shares of Nu Skin Enterprises during the fourth quarter valued at approximately $268,000. Finally, Symmetry Partners LLC grew its holdings in shares of Nu Skin Enterprises by 35.1% during the fourth quarter. Symmetry Partners LLC now owns 9,412 shares of the company’s stock valued at $514,000 after buying an additional 2,445 shares during the last quarter. 73.75% of the stock is owned by institutional investors and hedge funds.
A number of equities research analysts have recently commented on NUS shares. DA Davidson cut shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and cut their price target for the company from $71.00 to $58.00 in a report on Friday, February 12th. Jefferies Financial Group increased their price target on shares of Nu Skin Enterprises from $60.00 to $66.00 and gave the company a “buy” rating in a report on Tuesday, February 2nd. Six investment analysts have rated the stock with a hold rating and two have given a buy rating to the stock. Nu Skin Enterprises presently has an average rating of “Hold” and an average price target of $56.00.
Shares of NUS stock opened at $51.65 on Thursday. Nu Skin Enterprises, Inc. has a 12-month low of $21.78 and a 12-month high of $63.85. The company has a current ratio of 1.66, a quick ratio of 1.08 and a debt-to-equity ratio of 0.38. The firm’s 50 day moving average is $51.88 and its 200 day moving average is $53.37. The stock has a market capitalization of $2.63 billion, a P/E ratio of 17.39, a P/E/G ratio of 2.03 and a beta of 1.37.
Nu Skin Enterprises (NYSE:NUS) last issued its earnings results on Wednesday, February 10th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.19 by $0.21. Nu Skin Enterprises had a net margin of 6.54% and a return on equity of 19.18%. The company had revenue of $748.19 million for the quarter, compared to analysts’ expectations of $750.94 million. As a group, equities analysts predict that Nu Skin Enterprises, Inc. will post 3.4 earnings per share for the current year.
The business also recently announced a quarterly dividend, which was paid on Wednesday, March 10th. Investors of record on Friday, February 26th were issued a $0.38 dividend. The ex-dividend date was Thursday, February 25th. This represents a $1.52 annualized dividend and a yield of 2.94%. This is a boost from Nu Skin Enterprises’s previous quarterly dividend of $0.38. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently 49.03%.
Nu Skin Enterprises Profile
Nu Skin Enterprises, Inc develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
Featured Story: What is the 52-week high/low?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.